Physician profile
David D Park
NPI 1114986569
$111,603.52
in general payments reported to CMS, 2019-2025
12 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,235 · 2020: $14K · 2021: $18K · 2022: $18K · 2023: $17K · 2024: $19K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $48K · Long Term Medical Supply Or Device Loan: $7,200 · Travel and Lodging: $893 · Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $47,750.00 |
| Long Term Medical Supply Or Device Loan | $7,200.00 |
| Travel and Lodging | $893.13 |
| Food and Beverage | $410.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $95,250.00 | 2019-2025 | |
| Angiodynamics, INC. | $14,508.62 | 2019-2025 | Venacure 1470 Pro |
| Smith+Nephew, INC. | $1,170.64 | 2023 | Grafix, Stravix Pl, Oasis |
| Bard Peripheral Vascular, INC. | $221.20 | 2021-2022 | |
| Apyx Medical Corporation | $218.15 | 2020 | |
| Tactile Systems Technology INC | $84.86 | 2019-2020 | |
| Medtronic, INC. | $41.24 | 2023-2025 | Venaseal |
| Boston Scientific Corporation | $28.41 | 2025 | Varithena Administration Pack |
| Fidia Pharma USA INC. | $21.89 | 2025 | Hymovis, Triluron |
| Stryker Corporation | $21.13 | 2024 | N/A |
| Heron Therapeutics, INC. | $20.11 | 2023 | Zynrelef |
| Abbvie INC. | $17.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.